Australia invests $12m in heart protection research | Healthcare Asia Magazine
, Australia
Photo from Envato

Australia invests $12m in heart protection research

The funding will support the clinical trial of a peptide known as Hi1a.

The Australian government is set to invest nearly $12m (A$18m) in a research project that will trial a drug that protects the heart during a heart attack. The initiative will support a team from the University of Queensland, focusing on a peptide known as Hi1a.

The project, titled “The Heart Rehab Clinical Trials: Therapeutics to Protect the Human Heart”, will involve clinical trials using a miniaturised version of Hi1a to develop drugs for heart attack treatment and transplantation.

The funding is allocated through the Medical Research Future Fund's Frontier Health and Medical Research (Frontiers) grant opportunity.

According to the government, over 55,000 Australians experience a heart attack each year and approximately 7,000 fatalities result from these events.

A$1 = $0.67

 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!